Drugs don't work in patients who don't take them
231 Sheep LLC develops the Ocuelar platform, a medication adherence solution for glaucoma patients. The platform combines the Ocuelar SmartCap (a battery-free capsule that attaches to standard eyedrop bottles to monitor usage), the Ocuelar Patient App (a smartphone application providing analytics and adherence feedback to patients), and Ocuelar Admin (a cloud platform for physicians, caregivers, and relatives to monitor patient compliance). The company was founded after its chief medical officer observed Bay Area ophthalmology patients losing sight due to non-adherence to glaucoma medications.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
Create Free Account
